Monitoring requirements during the initial period include regular blood glucose checks if you have diabetes, particularly if you take insulin or sulfonylureas, as doses may need adjustment to prevent hypoglycaemia
New medications under FDA review, such as dual and triple agonists, are showing 20-30% weight loss in trials, monthly dosing options, and more flexible oral formulations are all in late-stage development
The semaglutide withdrawal symptoms guide discusses what happens when GLP-1 agonist levels fluctuate, and similar principles apply to retatrutide
Confirm the current details with CMS, Medicare.gov, your plan, and your healthcare provider before deciding anything
When Schorr stopped taking semaglutide, she said she started to notice she was regaining weight, but called the weight gain a "wake-up call." "I didn't realize how hungry I would get after like five to six weeks of being off of it," Schorr said
Alexander Shapsis describes this medication as a metabolic multi-tool. While existing drugs primarily focus on appetite, Retatrutide adds a direct fat-burning component